Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus.
Kaidar-Person O, Pfob A, Gentilini OD, Borisch B, Bosch A, Cardoso MJ, Curigliano G, De Boniface J, Denkert C, Hauser N, Heil J, Knauer M, Kühn T, Lee HB, Loibl S, Mannhart M, Meattini I, Montagna G, Pinker K, Poulakaki F, Rubio IT, Sager P, Steyerova P, Tausch C, Tramm T, Vrancken Peeters MJ, Wyld L, Yu JH, Weber WP, Poortmans P, Dubsky P. Kaidar-Person O, et al. Among authors: curigliano g. EClinicalMedicine. 2023 Jul 14;61:102085. doi: 10.1016/j.eclinm.2023.102085. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37528842 Free PMC article. Review.
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care.
Cardoso F, McCartney A, Ponti A, Marotti L, Vrieling C, Eniu A, Sousa B, Ripamonti C, Travado L, Spitz S, Jolly E, Curigliano G, Penault-Llorca F, Lecouvet F, Rubio IT, Biganzoli L. Cardoso F, et al. Among authors: curigliano g. Eur J Cancer. 2023 Jul;187:105-113. doi: 10.1016/j.ejca.2023.03.028. Epub 2023 Mar 31. Eur J Cancer. 2023. PMID: 37146504
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.
Pivot X, Gligorov J, Müller V, Curigliano G, Knoop A, Verma S, Jenkins V, Scotto N, Osborne S, Fallowfield L; PrefHer Study Group. Pivot X, et al. Among authors: curigliano g. Ann Oncol. 2014 Oct;25(10):1979-1987. doi: 10.1093/annonc/mdu364. Epub 2014 Jul 28. Ann Oncol. 2014. PMID: 25070545 Free article. Clinical Trial.
The multicenter experience in the multidisciplinary Italian breast units: a review and update.
Magnoni F, Tinterri C, Corso G, Curigliano G, Leonardi MC, Toesca A, Rocco N, Catalano F, Bianchi B, Lauria F, Caldarella P, Pagani G, Galimberti V, Veronesi P. Magnoni F, et al. Among authors: curigliano g. Eur J Cancer Prev. 2024 May 1;33(3):185-191. doi: 10.1097/CEJ.0000000000000853. Epub 2023 Nov 6. Eur J Cancer Prev. 2024. PMID: 37997909 Review.
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.
Carrera PM, Curigliano G, Santini D, Sharp L, Chan RJ, Pisu M, Perrone F, Karjalainen S, Numico G, Cherny N, Winkler E, Amador ML, Fitch M, Lawler M, Meunier F, Khera N, Pentheroudakis G, Trapani D, Ripamonti CI. Carrera PM, et al. Among authors: curigliano g. ESMO Open. 2024 May;9(5):102992. doi: 10.1016/j.esmoop.2024.102992. Epub 2024 Apr 15. ESMO Open. 2024. PMID: 38626634 Free PMC article.
The immunogram of inflammatory breast cancer.
Valenza C, Trapani D, Fusco N, Wang X, Cristofanilli M, Ueno NT, Curigliano G. Valenza C, et al. Among authors: curigliano g. Cancer Treat Rev. 2023 Sep;119:102598. doi: 10.1016/j.ctrv.2023.102598. Epub 2023 Jul 8. Cancer Treat Rev. 2023. PMID: 37437342 Review.
Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329].
Curigliano G, Mueller V, Borges V, Hamilton E, Hurvitz S, Loi S, Murthy R, Okines A, Paplomata E, Cameron D, Carey LA, Gelmon K, Hortobagyi GN, Krop I, Loibl S, Pegram M, Slamon D, Ramos J, Feng W, Winer E. Curigliano G, et al. Ann Oncol. 2023 Jul;34(7):630. doi: 10.1016/j.annonc.2022.12.005. Epub 2022 Dec 21. Ann Oncol. 2023. PMID: 36564285 No abstract available.
768 results